Skip to main content
Erschienen in: European Journal of Pediatrics 6/2020

03.02.2020 | Original Article

The triglyceride and glucose index is a useful biomarker to recognize glucose disorders in apparently healthy children and adolescents

verfasst von: Luis E. Simental-Mendía, Claudia I. Gamboa-Gómez, Celia Aradillas-García, Martha Rodríguez-Morán, Fernando Guerrero-Romero

Erschienen in: European Journal of Pediatrics | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

It has been suggested that the triglyceride and glucose (TyG) index is an early indicator for type 2 diabetes (T2D) in adults. Thus, the aim of this study was to evaluate whether the TyG index is useful in the screening of glucose disorders (GD) in apparently healthy children and adolescents. Eligible participants were apparently healthy children and adolescents. Individuals with new diagnosis of GD were allocated into the study groups with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and T2D. Participants with normal glucose tolerance (NGT) were the control group. In total, 1872 children and adolescents were enrolled and allocated into the study groups. Diagnosis of NGT, IFG, IGT, and T2D was established in 1541 (82.3%), 256 (13.7%), 66 (3.5%), and 9 (0.4%) children, respectively. In girls, the best cutoff points of the TyG index for identifying IFG, IGT, and T2D were 4.51 (sensitivity 59.8%, specificity 59.8%), 4.55 (sensitivity 63.0%, specificity 64.3%), and 4.63 (sensitivity 75.0%, specificity 74.6%), respectively; and in boys were 4.52 (sensitivity 62.8%, specificity 64.2%), 4.54 (sensitivity 71.8%, specificity 65.1%), and 4.82 (sensitivity 91.0%, specificity 990.6%), respectively.
Conclusion: Our results suggest that the TyG index may be a useful tool for screening GD in healthy children and adolescents.
What is Known:
Prevalence of prediabetes and type 2 diabetes is increasing worldwide among young adults and adolescents.
Elevated fasting glucose and triglyceride concentrations have been recognized as independent risk factors for type 2 diabetes.
What is New:
The TyG index exhibited highest sensitivity and specificity to detect impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes.
The TyG index may be a useful tool for the screening of glucose disorders in apparently healthy children and adolescents.
Literatur
2.
Zurück zum Zitat Ludwig DS, Ebbeling CB (2001) Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA. 286(12):1427–1430CrossRef Ludwig DS, Ebbeling CB (2001) Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA. 286(12):1427–1430CrossRef
4.
Zurück zum Zitat Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A, Israeli Diabetes Research Group (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353(14):1454–1462CrossRef Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A, Israeli Diabetes Research Group (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353(14):1454–1462CrossRef
6.
Zurück zum Zitat Simental-Mendía LE, Castañeda-Chacón A, Rodriguez-Morán M, Aradillas-García C, Guerrero-Romero F (2015) Relationship between elevated triglyceride levels with the increase of HOMA-IR and HOMA-β in healthy children and adolescents with normal weight. Eur J Pediatr 174(5):597–605. https://doi.org/10.1007/s00431-014-2426-z CrossRefPubMed Simental-Mendía LE, Castañeda-Chacón A, Rodriguez-Morán M, Aradillas-García C, Guerrero-Romero F (2015) Relationship between elevated triglyceride levels with the increase of HOMA-IR and HOMA-β in healthy children and adolescents with normal weight. Eur J Pediatr 174(5):597–605. https://​doi.​org/​10.​1007/​s00431-014-2426-z CrossRefPubMed
7.
Zurück zum Zitat Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167CrossRef Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167CrossRef
10.
12.
Zurück zum Zitat Sacks D, Canadian Paediatric Society, Adolescent Health Committee (2003) Age limits and adolescents. Paediatr Child Health 8(9):577–578CrossRef Sacks D, Canadian Paediatric Society, Adolescent Health Committee (2003) Age limits and adolescents. Paediatr Child Health 8(9):577–578CrossRef
14.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42:1206–1252CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42:1206–1252CrossRef
15.
Zurück zum Zitat Lee SH, Han K, Yang HK, Kim MK, Yoon KH, Kwon HS, Park YM (2015) Identifying subgroups of obesity using the product of triglycerides and glucose: the Korea National Health and Nutrition Examination Survey, 2008-2010. Clin Endocrinol 82:213–220CrossRef Lee SH, Han K, Yang HK, Kim MK, Yoon KH, Kwon HS, Park YM (2015) Identifying subgroups of obesity using the product of triglycerides and glucose: the Korea National Health and Nutrition Examination Survey, 2008-2010. Clin Endocrinol 82:213–220CrossRef
16.
Zurück zum Zitat Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X (2014) Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol 13:146CrossRef Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X (2014) Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol 13:146CrossRef
17.
Zurück zum Zitat Espinel-Bermúdez MC, Robles-Cervantes JA, Del Sagrario V-HL, Villaseñor-Romero JP, Hernández-González SO, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG (2015) Insulin resistance in adult primary care patients with a surrogate index, Guadalajara, Mexico, 2012. J Investig Med 63:247–250CrossRef Espinel-Bermúdez MC, Robles-Cervantes JA, Del Sagrario V-HL, Villaseñor-Romero JP, Hernández-González SO, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG (2015) Insulin resistance in adult primary care patients with a surrogate index, Guadalajara, Mexico, 2012. J Investig Med 63:247–250CrossRef
18.
Zurück zum Zitat Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL (2014) Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr 61:533–540CrossRef Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL (2014) Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr 61:533–540CrossRef
19.
Zurück zum Zitat Lucatello F, Vigna L, Carugno M, Tirelli AS, Bertazzi PA, Riboldi L (2012) Comparison of indexes for assessing insulin resistance for the health surveillance among workers. G Ital Med Lav Ergon 34(3 Suppl):748–749PubMed Lucatello F, Vigna L, Carugno M, Tirelli AS, Bertazzi PA, Riboldi L (2012) Comparison of indexes for assessing insulin resistance for the health surveillance among workers. G Ital Med Lav Ergon 34(3 Suppl):748–749PubMed
20.
Zurück zum Zitat Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93:e98–e100CrossRef Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93:e98–e100CrossRef
22.
Zurück zum Zitat Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia. 51(5):853–861. https://doi.org/10.1007/s00125-008-0951-x CrossRefPubMed Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia. 51(5):853–861. https://​doi.​org/​10.​1007/​s00125-008-0951-x CrossRefPubMed
23.
Zurück zum Zitat Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 48(11):2197–2203CrossRef Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 48(11):2197–2203CrossRef
24.
Zurück zum Zitat Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Holst JJ, Kuulasmaa T, Hribal ML, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U, EUGENE2 Consortium (2008) Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia. 51(3):502–511CrossRef Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Holst JJ, Kuulasmaa T, Hribal ML, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U, EUGENE2 Consortium (2008) Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia. 51(3):502–511CrossRef
25.
Zurück zum Zitat Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R (2006) Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 55(12):3536–3549CrossRef Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R (2006) Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 55(12):3536–3549CrossRef
26.
Zurück zum Zitat Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 55(5):1430–1435CrossRef Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 55(5):1430–1435CrossRef
27.
Zurück zum Zitat Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8):1909–1914CrossRef Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8):1909–1914CrossRef
28.
29.
Zurück zum Zitat American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Pediatrics. 105(3 Pt 1):671–680CrossRef American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Pediatrics. 105(3 Pt 1):671–680CrossRef
30.
Zurück zum Zitat Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 32(Suppl. 1):S168–S180 Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 32(Suppl. 1):S168–S180
34.
Zurück zum Zitat Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346(11):802–810CrossRef Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346(11):802–810CrossRef
35.
Zurück zum Zitat Di Bonito P, Pacifico L, Chiesa C, Valerio G, Miraglia Del Giudice E, Maffeis C, Morandi A, Invitti C, Licenziati MR, Loche S, Tornese G, Franco F, Manco M, Baroni MG, “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group (2017) Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity. J Endocrinol Investig 40(4):409–416. https://doi.org/10.1007/s40618-016-0576-8 Di Bonito P, Pacifico L, Chiesa C, Valerio G, Miraglia Del Giudice E, Maffeis C, Morandi A, Invitti C, Licenziati MR, Loche S, Tornese G, Franco F, Manco M, Baroni MG, “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group (2017) Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity. J Endocrinol Investig 40(4):409–416. https://​doi.​org/​10.​1007/​s40618-016-0576-8
Metadaten
Titel
The triglyceride and glucose index is a useful biomarker to recognize glucose disorders in apparently healthy children and adolescents
verfasst von
Luis E. Simental-Mendía
Claudia I. Gamboa-Gómez
Celia Aradillas-García
Martha Rodríguez-Morán
Fernando Guerrero-Romero
Publikationsdatum
03.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 6/2020
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-020-03570-2

Weitere Artikel der Ausgabe 6/2020

European Journal of Pediatrics 6/2020 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.